Biologics Contract Manufacturing Market Analysis: Investment, Innovation, and Growth Opportunities Through 2034
The global Biologics Contract Manufacturing Market is poised for exceptional growth from 2025 to 2033, fueled by the expanding biopharmaceutical industry, increasing complexity of biologic therapies, and the growing strategic shift toward outsourced manufacturing. The market was valued at approximately USD 23.6 billion in 2025 and is forecasted to reach nearly USD 55.4...
0 Commenti 0 condivisioni 18 Views 0 Anteprima
SocioMint https://sociomint.com